Furthermore, the repression of IL-8 and TGF-β signaling events in treated cells exhibits the potential regulatory influence of indicated PJ-1 and PJ-9 in the angiogenesis and metastases of cancer cells. The gene discussed is CXCL8; the disease is cancer.